Clair Health
Clair Health is a Mountain View, California-based women's health company founded in 2025 by Stanford graduates Jenny Duan (CEO) and Abhinav Agarwal (CTO).
About
Clair Health is a Mountain View, California-based women's health company founded in 2025 by Stanford graduates Jenny Duan (CEO) and Abhinav Agarwal (CTO). Its wearable, Clair, uses 10 biosensors and machine-learning models to non-invasively and continuously track estrogen, progesterone, LH, FSH and cycle phases.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Clair Health
Clair Health is a Mountain View, California-based women's health company founded in 2025 by Stanford graduates Jenny Duan (CEO) and Abhinav Agarwal (CTO). Its wearable, Clair, uses 10 biosensors and machine-learning models to non-invasively and continuously track estrogen, progesterone, LH, FSH and cycle phases.
$12M
$12M
United States
BusinessLatest roundTotal raisedDate- Karoo Health
Value-based care platform for cardiovascular disease, integrating clinical/claims/pharmacy/patient data for early risk identification and coordinated care
Series A · $16M · 2026-07
$16M - Valius Sciences
Precision oncology diagnostics: integrated molecular profiling of tumors across DNA/RNA/protein layers, assessing actionable targets across tumor types, target heterogeneity and resistance mechanisms, benchmarked against large tumor datasets, delivered to physicians and patients as interactive software + shareable data (not static PDF reports)
Seed · $14M · 2026-04
$14M - Dinamo Biotechnologies
Blood cfDNA-based dynamic biomarker platform using AI/machine learning to decode molecular signals, providing patient stratification and molecular response monitoring for immunology drug developers
—
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Skin Analytics
AI tool that assists skin cancer detection by identifying skin lesions from images
Series B · $20M · 2025-04
$20M - Oxford Cancer Analytics
AI-based blood tests for cancer detection
Series A · $11M · 2025-01
$11M - MyndBlue
Wearable and AI-based remote objective monitoring and early warning for depression and PTSD
—
Other / unspecified
BusinessLatest roundTotal raisedDate- Alimetry
Wearable medical devices that diagnose gastrointestinal disorders by mapping electrical activity on the body surface
Series A · $18M · 2024-10
$18M - Cent
Annual preventive health check protocol for consumers: whole-body MRI, low-dose CT, DEXA, ECG/ultrasound and 100+ blood and urine biomarkers, with an in-house AI system synthesizing multimodal imaging and biomarker data into health scores and risk ratings; runs its own clinical prevention centers in Bengaluru, Mumbai and Delhi NCR, and works with Siemens Healthineers to shorten scan times.
$5M
$5M - HoneyNaps
Uses advanced algorithms to analyze sleep data and provide accurate diagnostic insights
Series B · $12M · 2024-05
$12M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 22 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.